• Explore /
  • Poster
  • / <span>The association of FDG PET/CT and NaF PET/CT with survival outcomes in patients (pts) with metastatic genitourinary malignancies (mGU) treated with cabozantinib + nivolumab +/- ipilimumab (CaboNivo +/- Ipi).</span>

The association of FDG PET/CT and NaF PET/CT with survival outcomes in patients (pts) with metastatic genitourinary malignancies (mGU) treated with cabozantinib + nivolumab +/- ipilimumab (CaboNivo +/- Ipi).

Abstract Poster

Authors

null

Nicholas I. Simon

Northwestern University, Chicago, IL

Nicholas I. Simon , Katherine Lei , Nicholas Peter Verdini , Jeffrey Lin , Andy Vega , Scot Anthony Niglio , Amir Mortazavi , Sumanta K. Pal , Jeffrey Kempf , Murray Becker , Michael V. Knopp , Chadwick Wright , Alex Jung , Peter L. Choyke , Seth M. Steinberg , Esther Mena , Liza Lindenberg , Andrea B. Apolo

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Urothelial Carcinoma

Track

Urothelial Carcinoma

Sub Track

Diagnostics and Imaging

Citation

J Clin Oncol 40, 2022 (suppl 6; abstr 452)

DOI

10.1200/JCO.2022.40.6_suppl.452

Abstract #

452

Poster Bd #

C8

Abstract Disclosures

Similar Posters

First Author: Nicholas I. Simon

First Author: Andrea B. Apolo

First Author: Zishuo Hu

First Author: Andrea B. Apolo